AQP5: A Potential Drug Target Or Biomarker (G362)

Target Name: AQP5

NCBI ID: G362

AQP5

AQP5: A Potential Drug Target Or Biomarker

AQP5, or Aquaporin 5, is a water-excretory protein that is expressed in various body tissues and organs, including the brain, lungs, kidneys, and heart. It is a member of the AQP family, which includes six transmembrane proteins that are involved in water transport and regulation. The discovery of AQP5 as a potential drug target or biomarker has significant implications for several fields, including neurodegenerative diseases, urologic diseases, and renal diseases.

AQP5 is expressed in the brain and is involved in the regulation of water and electrolyte balance. It has been shown to play a crucial role in the maintenance of the brain's cellular homeostasis, as well as the regulation of the extracellular matrix (ECM) and the cell-cell interactions that are critical for brain function. Several studies have demonstrated that AQP5 is involved in the regulation of ion channels, neurotransmitter release, and neurotrophic factor (NTF) signaling, which are all critical for brain health and function.

In addition to its role in brain health, AQP5 is also expressed in other tissues and organs and has been shown to be involved in the regulation of essential physiological processes, including water and electrolyte balance in the kidneys and the regulation of blood pressure. It has been shown to play a critical role in the regulation of sodium and potassium levels in the body, which are critical for maintaining the proper electrical activity of cells and tissues.

As a potential drug target, AQP5 is of interest because of its role in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to contribute to the degenerative changes that occur in these conditions. Several studies have suggested that AQP5 may be a potential therapeutic target for these conditions, because inhibiting its activity could potentially help to reduce the progression of neurodegeneration.

In addition to its potential therapeutic applications, AQP5 is also of interest as a biomarker for several urologic and renal diseases. The regulation of water and electrolyte balance is critical for maintaining the proper functioning of the kidneys, and several studies have suggested that AQP5 may be involved in the regulation of these processes in these diseases. For example, several studies have shown that AQP5 is involved in the regulation of sodium and potassium levels in the urine, which is a critical indicator of the regulation of water and electrolyte balance. In addition, AQP5 has been shown to play a critical role in the regulation of urine output, which is another important indicator of the regulation of water and electrolyte balance.

Overall, the discovery of AQP5 as a potential drug target or biomarker has significant implications for several fields, including neurodegenerative diseases, urologic diseases, and renal diseases. Further research is needed to fully understand its role in these conditions and to develop effective therapies that can target its activity.

Protein Name: Aquaporin 5

Functions: Forms a water-specific channel (PubMed:8621489, PubMed:18768791). Plays an important role in fluid secretion in salivary glands (By similarity). Required for TRPV4 activation by hypotonicity. Together with TRPV4, controls regulatory volume decrease in salivary epithelial cells (PubMed:16571723). Seems to play a redundant role in water transport in the eye, lung and in sweat glands (By similarity)

The "AQP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AQP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets